Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project
One recently identified subtype of pediatric B-precursor acute lymphoblastic leukemia (ALL) has been termed BCR-ABL1-like or Ph-like because of similarity of the gene expression profile to BCR-ABL1 positive ALL suggesting the presence of lesions activating tyrosine kinases, frequent alteration of IK...
Uložené v:
| Vydané v: | Blood Ročník 121; číslo 3; s. 485 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
17.01.2013
|
| Predmet: | |
| ISSN: | 1528-0020, 1528-0020 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | One recently identified subtype of pediatric B-precursor acute lymphoblastic leukemia (ALL) has been termed BCR-ABL1-like or Ph-like because of similarity of the gene expression profile to BCR-ABL1 positive ALL suggesting the presence of lesions activating tyrosine kinases, frequent alteration of IKZF1, and poor outcome. Prior studies demonstrated that approximately half of these patients had genomic lesions leading to CRLF2 overexpression, with half of such cases harboring somatic mutations in the Janus kinases JAK1 and JAK2. To determine whether mutations in other tyrosine kinases might also occur in ALL, we sequenced the tyrosine kinome and downstream signaling genes in 45 high-risk pediatric ALL cases with either a Ph-like gene expression profile or other alterations suggestive of activated kinase signaling. Aside from JAK mutations and 1 FLT3 mutation, no somatic mutations were found in any other tyrosine kinases, suggesting that alternative mechanisms are responsible for activated kinase signaling in high-risk ALL. |
|---|---|
| AbstractList | One recently identified subtype of pediatric B-precursor acute lymphoblastic leukemia (ALL) has been termed BCR-ABL1-like or Ph-like because of similarity of the gene expression profile to BCR-ABL1 positive ALL suggesting the presence of lesions activating tyrosine kinases, frequent alteration of IKZF1, and poor outcome. Prior studies demonstrated that approximately half of these patients had genomic lesions leading to CRLF2 overexpression, with half of such cases harboring somatic mutations in the Janus kinases JAK1 and JAK2. To determine whether mutations in other tyrosine kinases might also occur in ALL, we sequenced the tyrosine kinome and downstream signaling genes in 45 high-risk pediatric ALL cases with either a Ph-like gene expression profile or other alterations suggestive of activated kinase signaling. Aside from JAK mutations and 1 FLT3 mutation, no somatic mutations were found in any other tyrosine kinases, suggesting that alternative mechanisms are responsible for activated kinase signaling in high-risk ALL. One recently identified subtype of pediatric B-precursor acute lymphoblastic leukemia (ALL) has been termed BCR-ABL1-like or Ph-like because of similarity of the gene expression profile to BCR-ABL1 positive ALL suggesting the presence of lesions activating tyrosine kinases, frequent alteration of IKZF1, and poor outcome. Prior studies demonstrated that approximately half of these patients had genomic lesions leading to CRLF2 overexpression, with half of such cases harboring somatic mutations in the Janus kinases JAK1 and JAK2. To determine whether mutations in other tyrosine kinases might also occur in ALL, we sequenced the tyrosine kinome and downstream signaling genes in 45 high-risk pediatric ALL cases with either a Ph-like gene expression profile or other alterations suggestive of activated kinase signaling. Aside from JAK mutations and 1 FLT3 mutation, no somatic mutations were found in any other tyrosine kinases, suggesting that alternative mechanisms are responsible for activated kinase signaling in high-risk ALL.One recently identified subtype of pediatric B-precursor acute lymphoblastic leukemia (ALL) has been termed BCR-ABL1-like or Ph-like because of similarity of the gene expression profile to BCR-ABL1 positive ALL suggesting the presence of lesions activating tyrosine kinases, frequent alteration of IKZF1, and poor outcome. Prior studies demonstrated that approximately half of these patients had genomic lesions leading to CRLF2 overexpression, with half of such cases harboring somatic mutations in the Janus kinases JAK1 and JAK2. To determine whether mutations in other tyrosine kinases might also occur in ALL, we sequenced the tyrosine kinome and downstream signaling genes in 45 high-risk pediatric ALL cases with either a Ph-like gene expression profile or other alterations suggestive of activated kinase signaling. Aside from JAK mutations and 1 FLT3 mutation, no somatic mutations were found in any other tyrosine kinases, suggesting that alternative mechanisms are responsible for activated kinase signaling in high-risk ALL. |
| Author | Kang, Huining Devidas, Meenakshi Raetz, Elizabeth Willman, Cheryl L Edmonson, Michael Larsen, Eric Zhang, Jinghui Becksfort, Jared Wu, Gang Roberts, Kathryn Carroll, William L Harvey, Richard C Downing, James R Payne-Turner, Debbie Chen, I-Ming Winick, Naomi Wood, Brent Chen, Xiang Gerhard, Daniela S Bowman, Paul Loh, Mignon L Buetow, Kenneth H Hunger, Stephen P Smith, Malcolm Borowitz, Michael J Mullighan, Charles G |
| Author_xml | – sequence: 1 givenname: Mignon L surname: Loh fullname: Loh, Mignon L organization: Department of Pediatrics and the Helen Diller Family Cancer Center, University of California-San Francisco, CA, USA – sequence: 2 givenname: Jinghui surname: Zhang fullname: Zhang, Jinghui – sequence: 3 givenname: Richard C surname: Harvey fullname: Harvey, Richard C – sequence: 4 givenname: Kathryn surname: Roberts fullname: Roberts, Kathryn – sequence: 5 givenname: Debbie surname: Payne-Turner fullname: Payne-Turner, Debbie – sequence: 6 givenname: Huining surname: Kang fullname: Kang, Huining – sequence: 7 givenname: Gang surname: Wu fullname: Wu, Gang – sequence: 8 givenname: Xiang surname: Chen fullname: Chen, Xiang – sequence: 9 givenname: Jared surname: Becksfort fullname: Becksfort, Jared – sequence: 10 givenname: Michael surname: Edmonson fullname: Edmonson, Michael – sequence: 11 givenname: Kenneth H surname: Buetow fullname: Buetow, Kenneth H – sequence: 12 givenname: William L surname: Carroll fullname: Carroll, William L – sequence: 13 givenname: I-Ming surname: Chen fullname: Chen, I-Ming – sequence: 14 givenname: Brent surname: Wood fullname: Wood, Brent – sequence: 15 givenname: Michael J surname: Borowitz fullname: Borowitz, Michael J – sequence: 16 givenname: Meenakshi surname: Devidas fullname: Devidas, Meenakshi – sequence: 17 givenname: Daniela S surname: Gerhard fullname: Gerhard, Daniela S – sequence: 18 givenname: Paul surname: Bowman fullname: Bowman, Paul – sequence: 19 givenname: Eric surname: Larsen fullname: Larsen, Eric – sequence: 20 givenname: Naomi surname: Winick fullname: Winick, Naomi – sequence: 21 givenname: Elizabeth surname: Raetz fullname: Raetz, Elizabeth – sequence: 22 givenname: Malcolm surname: Smith fullname: Smith, Malcolm – sequence: 23 givenname: James R surname: Downing fullname: Downing, James R – sequence: 24 givenname: Cheryl L surname: Willman fullname: Willman, Cheryl L – sequence: 25 givenname: Charles G surname: Mullighan fullname: Mullighan, Charles G – sequence: 26 givenname: Stephen P surname: Hunger fullname: Hunger, Stephen P |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23212523$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkE1LxDAYhIOsuOvHPxDJTS_V5O23N1l0FQRFel_y8daNmyY1aQ-9-dMtqOBphuFhYOaYLJx3SMg5Z9ecV3Ajrfc6AcYhYVmSARQ1PyArnkOVMAZs8c8vyXGMH4zxLIX8iCwhBQ45pCvy1UzBR-OQ7o3zHdKInyM6Zdw79S3tURsxBKOoUOOA1E5dv_PSijjMmcVxj50Rt1TQgL0PA22D7-iwQ7reGasDustIX5zy1r9PdBP82NPm7m1z39DX4D9QDafksBU24tmvnpDm4b5ZPybPL5un9d1zonKoh0Rr2bZKi5ZBUXIhVFooXbRa1iWksq5ZhboSUqDklWY5ZHlWsrLOq5SD5BxOyNVPbR_8PDAO285EhdYKh36MWw5lWhR8bpvRi190lB3qbR9MJ8K0_TsNvgFQvnPA |
| CitedBy_id | crossref_primary_10_1080_10428194_2022_2090550 crossref_primary_10_2217_pme_14_90 crossref_primary_10_1016_j_clml_2017_03_299 crossref_primary_10_3389_fonc_2014_00054 crossref_primary_10_1182_blood_2013_08_460311 crossref_primary_10_3390_cancers9010002 crossref_primary_10_1182_blood_2016_05_707653 crossref_primary_10_1080_10428194_2023_2197538 crossref_primary_10_1038_leu_2016_375 crossref_primary_10_1111_jcmm_18114 crossref_primary_10_1016_j_leukres_2022_106925 crossref_primary_10_1172_JCI127721 crossref_primary_10_3390_ijms22126411 crossref_primary_10_1097_MOP_0000000000000570 crossref_primary_10_1016_j_beha_2017_06_001 crossref_primary_10_1016_j_anndiagpath_2016_02_002 crossref_primary_10_1182_blood_2016_12_758979 crossref_primary_10_1182_blood_2017_06_743252 crossref_primary_10_4137_CIN_S11831 crossref_primary_10_1042_BJ20140712 crossref_primary_10_1200_JCO_2017_74_3617 crossref_primary_10_1038_leu_2014_256 crossref_primary_10_1002_cncr_29871 crossref_primary_10_1111_petr_14024 crossref_primary_10_1097_PPO_0000000000000343 crossref_primary_10_3390_cancers13081847 crossref_primary_10_1038_bmt_2014_114 crossref_primary_10_1182_blood_2012_10_462358 crossref_primary_10_1158_1078_0432_CCR_16_0115 crossref_primary_10_1111_bjh_17959 crossref_primary_10_1182_bloodadvances_2017009837 crossref_primary_10_1016_j_beha_2019_101095 crossref_primary_10_1016_j_ejca_2017_06_012 crossref_primary_10_1182_bloodadvances_2019000163 crossref_primary_10_1016_j_ejcped_2025_100304 crossref_primary_10_1016_j_exphem_2018_07_007 crossref_primary_10_1038_leu_2015_113 crossref_primary_10_1159_000452265 crossref_primary_10_3389_fcell_2022_942053 crossref_primary_10_1080_13543784_2021_1916466 crossref_primary_10_1016_j_cancergen_2014_11_003 crossref_primary_10_1016_j_ejmg_2015_11_010 crossref_primary_10_1038_s41467_022_28218_7 crossref_primary_10_3322_caac_21273 crossref_primary_10_1002_cncr_29573 crossref_primary_10_1007_s11899_018_0456_8 crossref_primary_10_1016_j_beha_2017_07_003 crossref_primary_10_1016_S2352_3026_20_30362_8 crossref_primary_10_5858_arpa_2019_0194_RA crossref_primary_10_1056_NEJMe1407477 crossref_primary_10_3389_fonc_2014_00108 crossref_primary_10_1007_s12288_014_0483_0 crossref_primary_10_1016_j_blre_2016_09_001 crossref_primary_10_1007_s00431_015_2565_x crossref_primary_10_1016_j_cancergen_2016_06_004 crossref_primary_10_3389_fonc_2014_00134 crossref_primary_10_3390_children11111329 crossref_primary_10_1038_nrclinonc_2015_38 crossref_primary_10_1038_s41467_022_28682_1 crossref_primary_10_1182_blood_2018_04_841676 crossref_primary_10_1016_j_clml_2020_08_011 crossref_primary_10_1080_10428194_2020_1861275 crossref_primary_10_1007_s44253_024_00054_1 crossref_primary_10_1080_14656566_2021_1931683 crossref_primary_10_1200_JCO_2015_64_6364 crossref_primary_10_1080_14737140_2022_2093718 crossref_primary_10_1002_pbc_25575 crossref_primary_10_1002_pbc_25975 crossref_primary_10_1097_MOH_0000000000000050 crossref_primary_10_1371_journal_pone_0160310 crossref_primary_10_1177_2040620715588916 crossref_primary_10_1038_onc_2013_129 crossref_primary_10_3390_genes12050687 crossref_primary_10_1016_j_clml_2024_08_005 crossref_primary_10_1200_EDBK_156628 crossref_primary_10_24287_1726_1708_2019_18_1_112_126 crossref_primary_10_1016_j_clml_2019_08_003 crossref_primary_10_1186_2162_3619_3_16 crossref_primary_10_1016_j_beha_2018_09_003 crossref_primary_10_1007_s11684_015_0381_3 crossref_primary_10_1053_j_seminhematol_2013_10_001 crossref_primary_10_1038_ng_2803 crossref_primary_10_1182_blood_2024026482 crossref_primary_10_1080_14656566_2017_1340938 crossref_primary_10_3390_cancers16050858 crossref_primary_10_1097_MOH_0000000000000045 crossref_primary_10_1182_blood_2023023153 crossref_primary_10_1016_j_jbior_2019_100647 crossref_primary_10_1053_j_seminhematol_2018_05_001 crossref_primary_10_1056_NEJMoa1403088 crossref_primary_10_1002_gcc_22245 crossref_primary_10_1002_cncr_29267 crossref_primary_10_1200_JCO_2014_55_4105 crossref_primary_10_3390_ijms21062193 crossref_primary_10_1126_scitranslmed_3008661 crossref_primary_10_1016_j_semcancer_2020_10_013 crossref_primary_10_1007_s12098_023_04782_8 crossref_primary_10_1111_bjh_12442 crossref_primary_10_3389_fimmu_2020_569117 crossref_primary_10_1038_s41698_023_00485_7 crossref_primary_10_1172_JCI81468 crossref_primary_10_1177_1093526616688753 crossref_primary_10_1182_blood_2014_11_612903 crossref_primary_10_1016_j_beha_2021_101331 crossref_primary_10_1038_s41375_019_0642_2 crossref_primary_10_1126_science_aaw4153 crossref_primary_10_1016_j_phrs_2015_06_007 crossref_primary_10_1016_j_clml_2025_05_013 crossref_primary_10_1111_imr_12235 crossref_primary_10_1038_s41409_019_0438_z crossref_primary_10_1016_j_bbmt_2019_08_010 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1182/blood-2012-04-422691 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Chemistry Biology Anatomy & Physiology |
| EISSN | 1528-0020 |
| ExternalDocumentID | 23212523 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NCI NIH HHS grantid: P30 CA118100 – fundername: NCI NIH HHS grantid: U10 CA098413 – fundername: NCI NIH HHS grantid: U24 CA114766 – fundername: NCI NIH HHS grantid: U10 CA98413 – fundername: NCI NIH HHS grantid: CA98543 – fundername: NCI NIH HHS grantid: U01 CA114762 – fundername: NCI NIH HHS grantid: U01 CA157937 – fundername: NCI NIH HHS grantid: U10 CA098543 |
| GroupedDBID | --- -~X .55 0R~ 23N 2WC 34G 39C 4.4 53G 5GY 5RE 5VS 6J9 AAEDW AALRI AAXUO ABOCM ACGFO ADBBV ADVLN AENEX AFOSN AITUG AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ BAWUL BTFSW CGR CS3 CUY CVF DIK DU5 E3Z EBS ECM EIF EJD EX3 F5P FDB FRP GS5 GX1 H13 IH2 K-O KQ8 L7B LSO MJL N9A NPM OK1 P2P R.V RHF RHI ROL SJN THE TR2 TWZ W2D W8F WH7 WOQ WOW X7M YHG YKV 7X8 ACVFH ADCNI AEUPX AFPUW AIGII AKBMS AKYEP EFKBS |
| ID | FETCH-LOGICAL-c529t-ddbffcdaf02671aac36cd6fdb9723b9908ed8abaeb18d052454707958312b112 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 135 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000313727500012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1528-0020 |
| IngestDate | Wed Oct 01 14:29:16 EDT 2025 Wed Feb 19 02:30:30 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c529t-ddbffcdaf02671aac36cd6fdb9723b9908ed8abaeb18d052454707958312b112 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://ashpublications.org/blood/article-pdf/121/3/485/990071/zh800313000485.pdf |
| PMID | 23212523 |
| PQID | 1273661972 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1273661972 pubmed_primary_23212523 |
| PublicationCentury | 2000 |
| PublicationDate | 2013-Jan-17 20130117 |
| PublicationDateYYYYMMDD | 2013-01-17 |
| PublicationDate_xml | – month: 01 year: 2013 text: 2013-Jan-17 day: 17 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Blood |
| PublicationTitleAlternate | Blood |
| PublicationYear | 2013 |
| SSID | ssj0014325 |
| Score | 2.4763255 |
| Snippet | One recently identified subtype of pediatric B-precursor acute lymphoblastic leukemia (ALL) has been termed BCR-ABL1-like or Ph-like because of similarity of... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 485 |
| SubjectTerms | Child Child, Preschool Disease-Free Survival Female fms-Like Tyrosine Kinase 3 - genetics fms-Like Tyrosine Kinase 3 - metabolism Gene Expression Regulation, Leukemic - physiology Humans Infant Janus Kinase 1 - genetics Janus Kinase 1 - metabolism Janus Kinase 2 - genetics Janus Kinase 2 - metabolism Male Neoplasm, Residual - enzymology Neoplasm, Residual - genetics Neoplasm, Residual - mortality Philadelphia Chromosome Precursor Cell Lymphoblastic Leukemia-Lymphoma - enzymology Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality Protein-Tyrosine Kinases - genetics Protein-Tyrosine Kinases - metabolism Receptors, Cytokine - genetics Receptors, Cytokine - metabolism Receptors, Purinergic P2Y - genetics Receptors, Purinergic P2Y - metabolism Signal Transduction - genetics Transcriptome |
| Title | Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/23212523 https://www.proquest.com/docview/1273661972 |
| Volume | 121 |
| WOSCitedRecordID | wos000313727500012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9tAEB7Spo9c0tZpXn0whdKellgrydLmElyTtIfGNUUU38w-ISSRnNgu-NafntnVipwKgVzEXvRAM8z37Tz2A_ic5SJ35CfMKSVog5L1mRIZZ8alXFA81IPQRPPnZzEel9OpmMSE2yK2VXYxMQRq02ifIz9KCGcJS0TBT-Y3zKtG-epqlNB4ApspURnf0lVM76sIWRpEVwmiSuZ5URydI0p91LaFE_pxXxrw46Qi-T_JDGBz9uqxn_katiPNxGHrF29gw9Y92BnWtMW-XuMXDI2fIaPeg-ffutXLUSf_1oMX57HqvgP_qjVhKS3x8qJuri3G_mtCPWwczju1D5R6tbR4tSYPaRTRcno5XtnVJT1UHqPEtkCBfqQFiXjiKE6Sf13grzocn73GkAzDavj7-2mFkzZP9Baqs9Nq9INF5Qamcy6WzBjlnDbSeX2rREqdDrQZOKO8xpkiACytKaWSBBSl6efcnyrWL0RepglXxAB34Wnd1HYfsCyMdrrgKrc2o92TUM44m5osN3nfFNkBfOrsMKMf5KsdsrbNajG7t8QB7LXGnM3bEzxmRCOJ2PH08AF3v4MtHiQwEpYU72HTUViwH-CZ_ru8WNx-DB5H1_Hk_A4MCOFD |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tyrosine+kinome+sequencing+of+pediatric+acute+lymphoblastic+leukemia%3A+a+report+from+the+Children%27s+Oncology+Group+TARGET+Project&rft.jtitle=Blood&rft.au=Loh%2C+Mignon+L&rft.au=Zhang%2C+Jinghui&rft.au=Harvey%2C+Richard+C&rft.au=Roberts%2C+Kathryn&rft.date=2013-01-17&rft.issn=1528-0020&rft.eissn=1528-0020&rft.volume=121&rft.issue=3&rft.spage=485&rft_id=info:doi/10.1182%2Fblood-2012-04-422691&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1528-0020&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1528-0020&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1528-0020&client=summon |